Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Britannia Life SciencesXCNQ:BLAB Days Payable is 2,092.03 as of Mar. 2026, which is 2% above its 10-year median of 2,057.10. The stock has 5 warning signs investors should review. Among 708 Biotechnology companies, Britannia Life Sciences ranks better than 91.81% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XCNQ:BLAB vs VRTX, REGN, MRNA: Days Payable Comparison
For the Biotechnology subindustry, Britannia Life Sciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Britannia Life Sciences Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Britannia Life Sciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Britannia Life Sciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Britannia Life Sciences's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Britannia Life Sciences (XCNQ:BLAB) has a Days Payable of 2,092.03 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Britannia Life Sciences and its competitors. This is near median its historical median of 2,057.10. Over the past decade, Britannia Life Sciences' Days Payable has ranged from 468.61 to 2,931.54. According to the industry distribution chart, Britannia Life Sciences ranks #58 out of 708 companies in the Biotechnology industry, placing it in the top 8.2%.
Is Britannia Life Sciences' Days Payable too high?
Britannia Life Sciences' current Days Payable of 2,092.03 is near median its 10-year median of 2,057.10. Over the past 10 years, this metric has ranged from a low of 468.61 to a high of 2,931.54. The Biotechnology industry median Days Payable is 111.17. Britannia Life Sciences' value of 2,092.03 is 1781.9% above this industry median. Based on the distribution chart, Britannia Life Sciences ranks #58 out of 708 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Britannia Life Sciences' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Britannia Life Sciences ranks #58 out of 708 companies for Days Payable. This places Britannia Life Sciences in the top 8% of its industry — outperforming the majority of peers. The industry median Days Payable is 111.17. Britannia Life Sciences' value of 2,092.03 is 1781.9% above this benchmark. Historically, Britannia Life Sciences' own Days Payable has ranged from 468.61 to 2,931.54 over the past decade. While the company's 10-year median is 2,057.10 vs. the industry median of 111.17, Britannia Life Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 111.17, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Britannia Life Sciences's current Days Payable of 2,092.03 is 1781.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Britannia Life Sciences and its competitors. For the Biotechnology industry, the median Days Payable is 111.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Britannia Life Sciences's current Days Payable is 2,092.03, which is near median its own 10-year median of 2,057.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Britannia Life Sciences stock overvalued right now?
Britannia Life Sciences (XCNQ:BLAB) has a current Days Payable of 2,092.03. The current Days Payable is 2,092.03, which is near median its 10-year median of 2,057.10 and 1781.9% above the Biotechnology industry median of 111.17. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Britannia Life Sciences (XCNQ:BLAB), the current Days Payable is 2,092.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Britannia Life Sciences Inc provides product testing, safety assessment, and manufacturing services to the cosmetic and consumer packaged goods industries in the United Kingdom and globally.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XCNQ:BLAB has been successfully added to your 
